Data gathered: December 21
AI Stock Analysis - Edwards Lifesciences (EW)
Analysis generated October 24, 2024. Powered by Chat GPT.
Edwards Lifesciences Corporation is a prominent American medical equipment company. Renowned for its innovative heart valve products, it primarily designs, manufactures, and markets technologies for structural heart disease, especially in relation to critical care and surgical monitoring. The company’s key product lines include transcatheter heart valves, surgical heart valves, and critical care products. With a focus on heart-related medical devices, Edwards Lifesciences serves a critical role in the healthcare sector and sees steady demand for its life-saving technologies.
Stock Alerts - Edwards Lifesciences (EW)
 |
Edwards Lifesciences | December 17 Insider Alert: Lippis Daniel J. is selling shares |
|
Edwards Lifesciences | December 10 Web Traffic is down by 39.5% over the last month. |
|
Edwards Lifesciences | December 10 Insider Alert: Ullem Scott B. is selling shares |
|
Edwards Lifesciences | December 7 Insider Alert: Chopra Daveen is selling shares |
Alternative Data for Edwards Lifesciences
About Edwards Lifesciences
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
| Price | $74.81 |
| Target Price | Sign up |
| Volume | 13,950,000 |
| Market Cap | $44.1B |
| Year Range | $59.7 - $93.78 |
| Dividend Yield | 0% |
| PE Ratio | 28.88 |
| Analyst Rating | 39% buy |
| Industry | Medical Devices |
In the news
 |
Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback?December 20 - Yahoo |
 |
Is the Options Market Predicting a Spike in Edwards (EW) Stock?December 19 - Yahoo |
 |
Edwards Lifesciences Co. (NYSE:EW) Receives $78.65 Average Price Target from AnalystsDecember 18 - ETF Daily News |
 |
Edwards Lifesciences (NYSE:EW) Stock Rating Upgraded by Bank of AmericaDecember 16 - ETF Daily News |
B of A Securities Upgrades Edwards Lifesciences (EW)December 16 - Fintel |
|
 |
Edwards Lifesciences just upgraded at BofA, here's whyDecember 16 - Thefly.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 1.38B | 717M | 1.09B | 3.07B | 403M | 0.670 |
| Q2 '24 | 1.4B | 736M | 1.1B | 366M | 404M | 0.700 |
| Q1 '24 | 1.61B | 875M | 1.21B | 352M | 526M | 0.660 |
| Q4 '23 | 1.49B | 842M | 1.18B | 370M | 368M | 0.640 |
| Q3 '23 | 1.5B | 790M | 993M | 385M | 423M | 0.590 |
Insider Transactions View All
| Lippis Daniel J. filed to sell 23,189 shares at $74.1. December 16 '24 |
| BOBO DONALD E JR filed to sell 46,936 shares at $71.8. December 9 '24 |
| Ullem Scott B. filed to sell 30,561 shares at $71.7. December 9 '24 |
| Markowitz Wayne filed to sell 9,494 shares at $73.3. December 6 '24 |
| Chopra Daveen filed to sell 27,583 shares at $73.3. December 6 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$88.95 0% | 46 |
 |
Intuitive SurgicalISRG |
$524.43 0% | 76 |
 |
MedtronicMDT |
$81.03 0% | 43 |
 |
StrykerSYK |
$364.6 0% | 50 |
 |
Becton Dickinson and CoBDX |
$227.68 0% | 37 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Nov 11, 24 | Buy | $1K - $15K |
| Ro Khanna |
Oct 8, 24 | Buy | $1K - $15K |
| Mike Kelly |
Jun 14, 24 | Sell | $1K - $15K |
Read more about Edwards Lifesciences (EW) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Edwards Lifesciences?
The Market Cap of Edwards Lifesciences is $44.1B.
What is Edwards Lifesciences' PE Ratio?
As of today, Edwards Lifesciences' PE (Price to Earnings) ratio is 28.88.
What is the current stock price of Edwards Lifesciences?
Currently, the price of one share of Edwards Lifesciences stock is $74.81.
How can I analyze the EW stock price chart for investment decisions?
The EW stock price chart above provides a comprehensive visual representation of Edwards Lifesciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Edwards Lifesciences shares. Our platform offers an up-to-date EW stock price chart, along with technical data analysis and alternative data insights.
Does EW offer dividends to its shareholders?
As of our latest update, Edwards Lifesciences (EW) does not offer dividends to its shareholders. Investors interested in Edwards Lifesciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Edwards Lifesciences?
Some of the similar stocks of Edwards Lifesciences are Boston Scientific, Intuitive Surgical, Medtronic, Stryker, and Becton Dickinson and Co.
.